Stocks fell on Iran news, ServiceNow and Tesla. AI plays Intel and Comfort Systems reported earnings late.
Researchers are advancing in vivo CAR-T cell engineering, which generates therapeutic immune cells directly inside patients, bypassing complex lab manufacturing. This approach could broaden access, ...